हिंदी में पढ़ें

Home
/Aurobindo Pharma

Aurobindo Pharma

Aurobindo Pharma approves Rs 800 crore buyback at premium; what it means for investors

Aurobindo Pharma approves Rs 800 crore buyback at premium; what it means for investors

Mon, April 6, 2026

From Lenskart to M&M, Stocks in Focus on D-Street | Stock Market | BSE | NSE

From Lenskart to M&M, Stocks in Focus on D-Street | Stock Market | BSE | NSE

Sun, February 15, 2026

9 Stocks To Buy For Long Term: Motilal Oswal picks stocks for 2026 with up to 49% upside; Lemon Tree Hotels, JSW Energy, Tata Steel on list

9 Stocks To Buy For Long Term: Motilal Oswal picks stocks for 2026 with up to 49% upside; Lemon Tree Hotels, JSW Energy, Tata Steel on list

Wed, February 11, 2026

Anil Singhvi’s Top Picks SBI Futures Buy, Aurobindo Pharma Sell Targets, Stoploss

Anil Singhvi’s Top Picks SBI Futures Buy, Aurobindo Pharma Sell Targets, Stoploss

Mon, May 12, 2025

Pharma stocks under pressure: Sun Pharma cracks 5%, Nifty Pharma down 2% after Trump’s big blow on US drug pricing

Pharma stocks under pressure: Sun Pharma cracks 5%, Nifty Pharma down 2% after Trump’s big blow on US drug pricing

Mon, May 12, 2025

Anil Singhvi’s Expert Buy Call on Aurobindo Pharma, Dr Reddy’s, Lupin Futures

Anil Singhvi’s Expert Buy Call on Aurobindo Pharma, Dr Reddy’s, Lupin Futures

Thu, April 3, 2025

RECOMMENDED

Aurobindo Pharma to commence supplies to Europe from China plant in April

Aurobindo Pharma to commence supplies to Europe from China plant in April

Sun, February 16, 2025

Aurobindo unit gets USFDA nod for generic cancer drug

Aurobindo unit gets USFDA nod for generic cancer drug

Thu, December 5, 2024

Aurobindo Pharma unit gets first product approval from USFDA

Aurobindo Pharma unit gets first product approval from USFDA

Wed, September 11, 2024

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

Fri, August 16, 2024

Analyzing Aurobindo Pharma's Recent Action

Analyzing Aurobindo Pharma's Recent Action

Mon, July 15, 2024

Stock of the Day : Today Anil Singhvi gave buying advice in Aurobindo Pharma Futures

Stock of the Day : Today Anil Singhvi gave buying advice in Aurobindo Pharma Futures

Mon, July 15, 2024

This midcap pharma company gains over 2%,inches close to its 52-week high price: Check details

This midcap pharma company gains over 2%,inches close to its 52-week high price: Check details

Tue, May 28, 2024

Post-Results Analysis: Which Stocks to Buy? Insights by Anil Singhvi

Post-Results Analysis: Which Stocks to Buy? Insights by Anil Singhvi

Mon, May 27, 2024

Dr Reddy's, Sun Pharma, Aurobindo recall products in US

Dr Reddy's, Sun Pharma, Aurobindo recall products in US

Sun, May 19, 2024

Aurobindo Pharma gets tax demand of over Rs 13 crore, including interest, penalty

Aurobindo Pharma gets tax demand of over Rs 13 crore, including interest, penalty

Fri, May 3, 2024

Inside Aurobindo Pharma: Exploring the Force Behind its Dynamic Actions

Inside Aurobindo Pharma: Exploring the Force Behind its Dynamic Actions

Mon, April 1, 2024

Stock of the Day : Anil Singhvi gives buying opinion in Aurobindo Pharma

Stock of the Day : Anil Singhvi gives buying opinion in Aurobindo Pharma

Mon, April 1, 2024

Aurobindo Pharma shares gain up to 4% on commissioning four state-of-the-art manufacturing facilities

Aurobindo Pharma shares gain up to 4% on commissioning four state-of-the-art manufacturing facilities

Mon, April 1, 2024

Aurobindo Pharma shares gain after drug maker wins US regulator approval for nasal spray

Aurobindo Pharma shares gain after drug maker wins US regulator approval for nasal spray

Wed, March 20, 2024

1
2
3
4
5

Top News